Matters of legal in nature including licensing, intellectual property, and lawsuits.
CHELMSFORD, Mass., June 27, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that the Company’s management will participate in the 11th Annual CEO Investor Summit 2019, on Wednesday, July 10, 2019 at the St. Regis Hotel in San Francisco, California. About The 11th Annual CEO Investor SummitThe CEO Summit features a “round-robin” format... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Ariosa Diagnostics, Inc. The Court found that Ariosa’s Harmony non-invasive prenatal test infringed EP 1 524 321 and that the... Read more
JUNE 17, 2019 MINNEAPOLIS, June 17, 2019 /PRNewswire/ — Bio-Techne today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its ExoDx Prostate IntelliScore (EPI) test, making it the first exosome-based liquid biopsy test to receive a Breakthrough Device Designation. This designation not only validates the clinical importance of... Read more
By GlobeNewswire, June 17, 2019, 05:30:00 AM EDT: Source Arrayit Corporation Sunnyvale, June 17, 2019 (GLOBE NEWSWIRE) — Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, in accordance with the provisions of the Business and Professions Code has received licensure extension from the California Department of Public Health (CDPH) to operate a clinical laboratory... Read more
JUNE 13, 2019 The EPI prostate biopsy rule-out test is now available in every state MINNEAPOLIS, June 13, 2019 /PRNewswire/ — Bio-Techne today announced that it has received a clinical laboratory permit from the New York State Department of Health to provide its ExoDx Prostate IntelliScore (EPI) test in New York, providing a valuable tool to help... Read more
Thermo Fisher Scientific’s Oncomine Dx Target Test Receives Reimbursement Coverage in Japan CARLSBAD, Calif., June 3, 2019 /PRNewswire/ — Thermo Fisher Scientific today announced that its Oncomine Dx Target Test CDx System has received reimbursement coverage from Japan’s Ministry of Health, Labour and Welfare and is now commercially available in that country. The next-generation sequencing (NGS)-based... Read more
Thermo Fisher Scientific and Scinogy Partner to Accelerate Cell and Gene Therapy Commercialization CARLSBAD, Calif., May 29, 2019 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Scinogy, specialists in closed, automated manufacturing systems for cell therapies, to develop and commercialize fit-for-purpose instrumentation and reagent systems aimed at... Read more
Chicago, IL, US, May 28, 2019 – GE Healthcare and World Courier, a part of AmerisourceBergen, are combining their expertise in manufacturing and logistics to better patient access to cell and gene therapies. Together, they aim to create a seamless end-to-end supply chain that will enable the developers of these treatments to meet increasing global... Read more
CHELMSFORD, Mass., May 24, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that company management will participate in two upcoming investor conferences: Jefferies Global Health Care Investor Conference in New York on June 5, 2019 with a presentation at 9:00 a.m. EDT. Stifel Nicholas Cross Sector Insight Conference at the Intercontinental Hotel in Boston... Read more
U.S. Health Economic Analysis Demonstrates the Cost Reduction Impact of Using B⋅R⋅A⋅H⋅M⋅S PCT to Support Antibiotic Stewardship Versus Standard of Care Outcome shows a reduction in antibiotic days, shorter length of stay, shorter duration of mechanical ventilation, and fewer patients at risk for antibiotic resistance or C.difficile infection lead to incremental reduction of costs of... Read more